# A Study Evaluating Bacillus Cereus in the Prevention of Afatinib-associated Diarrhea

> **NCT03486587** · PHASE2 · TERMINATED · sponsor: **Sun Yat-sen University** · enrollment: 12 (actual)

## Conditions studied

- Diarrhea
- Treatment Side Effects

## Interventions

- **DRUG:** Bacillus Cereus tablets

## Key facts

- **NCT ID:** NCT03486587
- **Lead sponsor:** Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2018-04-15
- **Primary completion:** 2020-08-31
- **Final completion:** 2020-12-31
- **Target enrollment:** 12 (ACTUAL)
- **Why stopped:** Participants have better treatment selection, resulting in a slow recruitment.
- **Last updated:** 2021-10-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03486587

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03486587, "A Study Evaluating Bacillus Cereus in the Prevention of Afatinib-associated Diarrhea". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03486587. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*